Other studies have found that CSF α-synuclein levels did not differ significantly between dementia with Lewy bodies and Alzheimer’s disease patients [387] and between Alzheimer’s disease patients and patients with Parkinson’s disease and dementia with Lewy bodies [388]. This evidence concerns the gene SNCA and Parkinson disease.